Internet Explorer 11 is not supported. For an optimal experience, please visit our site in another browser.

  • Google launches new AI tools

    01:47

  • Representative George Santos pleads not guilty to 13 criminal charges

    02:39

  • E. Jean Carroll ‘overjoyed’ by verdict in Trump civil case

    02:12

  • Street artist transforms signs in New York City

    01:45

  • playing now

    New peanut allergy treatment could save young children’s lives, researchers say

    01:28

  • UNTIL NEXT TIME

    Record number of migrants crossing into the US one day before Title 42 ends

    02:42

  • Widow who wrote children’s book about grief accused of murdering her husband

    01:41

  • Jury finds Trump sexually abused, defamed E. Jean Caroll in civil trial

    03:56

  • HCA hospital nurses would have owed thousands if they had left within 2 years: investigation

    04:08

  • 8-year-old boy survives in the wild after being separated from his family for two days

    01:15

  • Women should get screened for breast cancer at 40 instead of 50, according to new guidelines

    01:23

  • Border communities brace for immigrant influx ahead of Title 42 expected end

    01:47

  • Biden meets with congressional leaders on US debt limit

    02:33

  • DOJ Files Charges Against Rep. George Santos, Three Sources Say

    01:14

  • Protesters detained after demanding justice for fatal strangulation in subway

    01:59

  • California closer to possibly paying descendants of enslaved people in reparations

    02:33

  • Floods Fuel New California Gold Rush

    01:46

  • Biden announces new travel compensation plan for flight delays and cancellations

    01:39

  • Alex Murdaugh admits to lying about the housekeeper’s death

    01:40

  • Texas driver accused of crashing SUV into migrants charged with manslaughter

    02:32

Researchers say a breakthrough therapy for children ages one to three with peanut allergies will save lives. It is a patch that provides peanut protein to the skin. NBC News’ Dana Griffin has more details.

Por Tess B. Loftis